1. Home
  2. |Insights
  3. |BTI Names Crowell & Moring a Litigation Leader

BTI Names Crowell & Moring a Litigation Leader

Firm News | 1 min read | 10.29.21

Washington, D.C. – October 29, 2021: BTI Consulting Group has named Crowell & Moring a Litigation Leader in Complex Commercial Litigation and Securities and Finance Litigation in its "BTI Litigation Outlook 2022: Post Pandemic and Beyond" report. The list highlights law firms that general counsel and other high-ranking corporate decision-makers identified as “the firms best suited to meet their most pressing litigation needs.”

To assemble the list, BTI conducted more than 350 phone interviews with leading corporate legal decision makers at large organizations with $1 billion or more in annual revenue. Companies taking part in the 2022 study research are representative of 15 industry segments and have an average annual income of $24.8 billion.

Founded in 1989, BTI Consulting Group benchmarks how Fortune 1000 companies buy and evaluate professional service providers.

About Crowell & Moring LLP

Crowell & Moring LLP is an international law firm with offices in the United States, Europe, MENA, and Asia that represents clients in litigation and arbitration, regulatory and policy, and transactional and corporate matters. The firm is internationally recognized for its representation of Fortune 500 companies in high-stakes litigation and government-facing matters, as well as its ongoing commitment to pro bono service and diversity, equity, and inclusion.

Insights

Firm News | 1 min read | 03.11.25

Crowell & Moring Represents Nuclear Energy Startup Atomic Alchemy in its Acquisition by Oklo

March 11, 2025: Oklo Inc. (NYSE: OKLO), an advanced nuclear technology company, announced on March 5, 2025 that it has closed the $25 million acquisition of Crowell client Atomic Alchemy Inc. (“Atomic Alchemy”), a leading innovator in radioisotope production. Oklo intends to use this strategic acquisition to establish a more reliable domestic supply chain for high-value radioisotopes critical to healthcare, research, and defense sectors and provides synergies to Oklo’s fuel recycling and nuclear energy businesses. Demand for radioisotopes is expected to increase significantly over the next decade, while global supply struggles to keep pace due to aging reactor infrastructure and a fragmented global supply chain, which at present is dominated by countries outside the United States. Atomic Alchemy intends to be a low-cost U.S. radioisotope producer that can provide a secure and domestic supply of radioisotopes to U.S. companies commercializing innovative radioisotope applications. With its proprietary VIPR® technology, Atomic Alchemy is building the first scalable production facility to provide a reliable, sustainable source of high-value radioisotopes. Using a vertically integrated model and fuel recycling, in partnership with Oklo, Atomic Alchemy is transforming isotope production to address global shortages, support critical applications, and strengthen national security. The core deal team included Samuel Holland Edwards, Jon O’Connell, Justin Lurie, and Ryan Flynn....